May 27
B.C. expands use of biosimilars to offer coverage for more treatment options
British Columbia is improving the sustainability of its PharmaCare program by expanding the use of biosimilars, which will create opportunities for new drug listings and boost existing coverage for patients.
The Arthritis Society is gratified that our patient-focused recommendations to the...
Public